Assessing the endocrine-disrupting potential of a substance rarely comes down to reviewing a single study or obtaining a simple positive or negative result. The real challenge lies in interpreting all available data: what is already known about the substance? Do the existing data adequately address endocrine activity and potential adverse effects?
